Biotechnology Stocks
| # | Son 7 Gün | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1951 |  AUPH Aurinia Pharmaceuticals Inc - Common Shares | 15.92 USD | -1.85% | -2.39% | +0.25% | +33.45% | 2.05 B USD | ||
| 1958 |  SRPT Sarepta Therapeutics, Inc. - Common Stock | 19.85 USD | +0.30% | +11.14% | +24.92% | +4.75% | 2.10 B USD | ||
| 1960 |  SION Sionna Therapeutics, Inc. - Common Stock | 43.69 USD | -2.76% | +4.20% | +34.10% | +11.06% | 1.97 B USD | ||
| 1972 |  VRDN Viridian Therapeutics, Inc. - Common Stock | 19.50 USD | -4.74% | +2.63% | +22.18% | -13.14% | 2.01 B USD | ||
| 1977 |  GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 23.32 USD | -4.43% | -4.66% | +33.33% | +106.37% | 1.97 B USD | ||
| 1997 |  ATAI AtaiBeckley Inc. - Common Stock | 5.09 USD | -1.93% | -2.30% | +32.90% | +28.86% | 1.87 B USD | ||
| 1999 |  STOK Stoke Therapeutics, Inc. - Common Stock | 31.71 USD | -3.97% | -2.37% | +7.67% | +160.34% | 1.97 B USD | ||
| 2000 |  BCAX Bicara Therapeutics Inc. - Common Stock | 28.30 USD | -6.91% | -2.51% | +38.73% | +95.98% | 1.86 B USD | ||
| 2002 |  ZYME Zymeworks Inc. - Common Stock | 26.03 USD | -2.58% | +2.40% | +6.64% | +46.73% | 1.90 B USD | ||
| 2008 |  PGEN Precigen, Inc. - Common Stock | 5.48 USD | -0.54% | -1.44% | +49.73% | +214.94% | 1.95 B USD | ||
| 2009 |  ANAB AnaptysBio, Inc. - Common Stock | 64.91 USD | -3.59% | -2.45% | +24.54% | +84.40% | 1.89 B USD | ||
| 2018 |  AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 17.43 USD | -4.07% | -3.06% | +31.55% | +149.71% | 1.94 B USD | ||
| 2021 |  RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.65 USD | -4.95% | -0.82% | +9.61% | -33.03% | 1.93 B USD | ||
| 2022 |  TYRA Tyra Biosciences, Inc. - Common Stock | 31.59 USD | -1.10% | +4.60% | +15.97% | +120.29% | 1.88 B USD | ||
| 2029 |  NUVB Nuvation Bio Inc. Class A Common Stock | 5.51 USD | -2.82% | +1.29% | +8.46% | +157.48% | 1.92 B USD | ||
| 2039 |  IOVA Iovance Biotherapeutics, Inc. - Common Stock | 4.22 USD | -2.99% | +5.24% | +3.18% | +133.15% | 1.88 B USD | ||
| 2041 |  TSHA Taysha Gene Therapies, Inc. - Common Stock | 6.29 USD | -3.23% | -5.84% | +14.16% | +155.69% | 1.81 B USD | ||
| 2054 |  NBTX Nanobiotix S.A. - ADSs | 38.35 USD | -1.16% | -1.29% | +8.12% | +619.51% | 1.86 B USD | ||
| 2061 |  URGN UroGen Pharma Ltd. - Ordinary Shares | 37.03 USD | -1.91% | -2.76% | +32.34% | +94.89% | 1.80 B USD | ||
| 2074 |  ZBIO Zenas BioPharma, Inc. - Common Stock | 26.62 USD | -3.83% | -3.97% | +49.63% | +0.60% | 1.68 B USD |
Haberler Biotechnology Stocks
BofA, tahkim kararı sonrası Beam hisse görüşünü korudu
Beam Therapeutics hisseleri neden düşüyor?
Prime Medicine hisseleri neden bugün yükseliyor?
Incyte hissesi 118,77 dolarda 52 haftalık zirve yaptı
Prime Medicine hisseleri Beam ile kazanılan tahkimden sonra yükseldi
Edgewise Therapeutics hissesi 43,96 dolarla rekor kırdı
Stifel, Vertex satın alımı sonrası Crinetics hissesini tut’a düşürdü
Gainers Biotechnology Stocks
 TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.36 | +40.65% |
 ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0249 | +24.50% |
 ELTX Elicio Therapeutics, Inc. - Common Stock | 3.38 | +20.71% |
 APLMW Apollomics Inc. - Warrant | 0.0143 | +19.17% |
 CBUS Cibus, Inc. - Class A Common Stock | 1.76 | +17.33% |
 TTRX Turn Therapeutics Inc. - Common Stock | 11.37 | +17.10% |
 PRME Prime Medicine, Inc. - Common Stock | 4.57 | +14.54% |
 SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.41 | +13.25% |
Losers Biotechnology Stocks
 CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.05 | -25.99% |
 BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.84 | -19.23% |
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0140 | -16.67% |
 JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
 LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
 MCRB Seres Therapeutics, Inc. - Common Stock | 7.16 | -12.04% |
 TVGNW Tevogen Bio Holdings Inc. - Warrant | 0.0501 | -11.64% |
 ONCO Onconetix, Inc. - Common Stock | 0.95 | -11.21% |